Skip to main content
DrugPrice

Patient Assistance Program (PAP)

A manufacturer-sponsored program that provides free or discounted drugs to patients who meet income and insurance eligibility requirements.

How It Works

Most major drug manufacturers operate PAPs for their brand-name products. Eligibility typically requires U.S. residency, income below 300-400% of the federal poverty level, and lack of adequate insurance coverage. PAPs can provide drugs completely free or at significantly reduced cost. These programs exist partly as a safety net and partly as a business strategy: they build brand loyalty and keep patients on the brand-name drug rather than switching to competitors. NeedyMeds.org and RxAssist.org maintain searchable databases of available PAPs. In 2022, PAPs provided over $18 billion in free medications.

Related Terms

  • Out-of-Pocket CostThe amount a patient pays directly for a prescription drug — including copays, coinsurance, and deductible payments.
  • Copay Card (Copay Coupon)A manufacturer-provided discount card that reduces or eliminates a patient's out-of-pocket copay for a brand-name drug — effectively making the drug free for patients with commercial insurance.

About This Definition

This definition is part of the DrugPrice Drug Pricing Glossary34 terms explaining how prescription drug pricing works in the United States. All definitions are written in plain language for patients, caregivers, journalists, and healthcare professionals.